drugset / Trial / NCT06026553

Assessing Ketorolac (Toradol) at Oocyte Retrieval

NCT06026553

RandomizedParallel-groupTriple-blindSupportive care

Summary

To determine if a nonsteroidal anti-inflammatory drug (NSAID), Ketorolac (Toradol), can improve pain control and decrease narcotic use after undergoing egg retrieval.

Timeline

Start
2022-08-10
Primary completion
2023-12
Completion
2025-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 15 mg Intravenous
Subject Ketorolac Other / unclassified 30 mg Intravenous

Indications